# Baxalta Belgium Manufacturing SA - Inspection Records

Source: https://www.globalkeysolutions.net/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9

> Inspection records and compliance data for Baxalta Belgium Manufacturing SA in Lessines, None. Access full analysis and detailed observations.

---

## Details

- Name: Baxalta Belgium Manufacturing SA
- FEI Number: 3002806503
- City: Lessines
- State: None
- Country Name: Belgium
- Address Line 1: Boulevard Rene Branquart 80
- Zip Code: None

## Related Documents

- [483 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.globalkeysolutions.net/records/483/baxalta-belgium-manufacturing-sa/d58d9b78-e7e5-42a0-b2c8-6d8a4357eb4f) — source: FDA, date: November 22, 2024
- [483 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.globalkeysolutions.net/records/483/baxalta-belgium-manufacturing-sa/6605c825-fc8a-48a9-adec-e289950a147a) — source: FDA, date: November 22, 2024
- [FDA Inspection 1251969 - Baxalta Belgium Manufacturing SA - 2024-11-22](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/115e13ec-e43f-4a5d-a6ea-a44fb33f7402) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2024
- [FDA Inspection 1093550 - Baxalta Belgium Manufacturing SA - 2019-05-31](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/cd4ac129-b584-44b0-be5e-b240449bbf4c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2019
- [483 - Baxalta Belgium Manufacturing SA - 2019-05-20](https://www.globalkeysolutions.net/records/483/baxalta-belgium-manufacturing-sa/6dbcde81-2291-4b42-a556-6dc3897f5b55) — source: FDA, date: May 20, 2019
- [FDA Inspection 918229 - Baxalta Belgium Manufacturing SA - 2015-02-24](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/517a0fe7-a773-4b40-a359-fba5e341e1c6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2015
- [FDA Inspection 918229 - Baxalta Belgium Manufacturing SA - 2015-02-24](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/c3d349dd-96b7-4ba0-8825-6438659630b9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 24, 2015
- [FDA Inspection 841219 - Baxalta Belgium Manufacturing SA - 2013-06-18](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/23cdccd0-46d0-4c57-a5a1-f0ad4715baa9) — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2013
- [FDA Inspection 841219 - Baxalta Belgium Manufacturing SA - 2013-06-18](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/1390dc0d-f01d-499b-ba27-14aca059294b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 18, 2013
- [FDA Inspection 827427 - Baxalta Belgium Manufacturing SA - 2013-03-19](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/28869407-e513-4cb0-99b7-af0914802c7a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 19, 2013
- [FDA Inspection 712920 - Baxalta Belgium Manufacturing SA - 2011-01-21](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/57ba0239-ccad-4fd3-bc2b-413d013423bb) — classification: Official Action Indicated (OAI), source: FDA, date: January 21, 2011
- [FDA Inspection 622355 - Baxalta Belgium Manufacturing SA - 2009-10-19](https://www.globalkeysolutions.net/records/fda_inspections/baxalta-belgium-manufacturing-sa/0e1f4568-500c-413f-9bb0-12e8e9853325) — classification: Official Action Indicated (OAI), source: FDA, date: October 19, 2009

## Related Companies

- [Nordmark Arzneimittel GMBH & Co. KG](https://www.globalkeysolutions.net/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b)
- [Cilag AG](https://www.globalkeysolutions.net/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Bristol-Myers Squibb Company](https://www.globalkeysolutions.net/companies/bristol-myers-squibb-company/b20ef646-d409-4268-af48-ddf4c16f82cc)
- [Aprecia Pharmaceuticals LLC](https://www.globalkeysolutions.net/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)
- [Advanced Accelerator Applications (Italy) srl](https://www.globalkeysolutions.net/companies/advanced-accelerator-applications-italy-srl/09ac059c-6735-4082-8674-a88476dbdbc6)
- [AgroChem USA, LLC](https://www.globalkeysolutions.net/companies/agrochem-usa-llc/007b3455-bf3c-4d23-b1e7-0be79ebba21e)
- [OMRIX Biopharmaceuticals LTD](https://www.globalkeysolutions.net/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d)
- [Amgen, Inc.](https://www.globalkeysolutions.net/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8)
- [Novartis Pharma Stein AG](https://www.globalkeysolutions.net/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b)
- [Merck Sharp & Dohme LLC](https://www.globalkeysolutions.net/companies/merck-sharp-dohme-llc/842c6e25-ee89-453c-a5b0-6b039c187744)

## Related Officers

- [Program Expert for Advanced Manufacturing ](https://www.globalkeysolutions.net/people/prabhu-p-raju/2c0aaede-fe16-4431-bc21-614d7f18cb32)
- [investigator](https://www.globalkeysolutions.net/people/yonggang-wang/5c7dd00f-f810-4f86-9c78-51ae7f4b8acd)
- [Alan L. Truong](https://www.globalkeysolutions.net/people/alan-l-truong/8b9c59ed-ce68-44c3-9fbe-07cc3da13713)
- [issuing_officer](https://www.globalkeysolutions.net/people/malgorzata-g-norton/ba7b8827-0976-4abd-8abb-95d4222d2bdc)